Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.
Related ArticlesLong-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease. Clin Neuropharmacol. 2019 Apr 30;: Authors: Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N Abstract OBJECTIVES: The aim of this open-label study was to investigate the long-term safety and efficacy of selegiline as monotherapy in Japanese patients with early Parkinson disease ... read more
Source: PubMedPublished on 2019-05-03